Авторы

  • Хайдарова Д.К.
  • Садуллаев Д.И.

Ключевые слова:

хроническая обструктивная болезнь легких, когнитивные нарушения, гипоксия, гипоксемия, окислительный стресс, митохондриальная дисфункция, нейровоспаление, эндотелиальная дисфункция, сердечно-сосудистая коморбидность, церебральная гипоперфузия, нейродегенерация.

Библиографические ссылки

1. Barnes P.J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.

2. Agustí A., Celli B., Faner R. What does endotyping mean for treatment in chronic obstructive pulmonary disease? Lancet. 2018;391(10126):177 1–1772.

3. GOLD. Global Strategy for the Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease: 2026 Report. Global Initiative for Chronic Obstructive Lung Disease; 2026.

4. Dodd J.W. Lung disease as a determinant of cognitive decline and dementia. Ageing Res Rev. 2015;23(Pt B):39–49.

5. Dodd J.W., Getov S.V., Jones P.W. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922.

6. Thakur N., Blanc P.D., Julian L.J., et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2010;5:263–269.

7. Incalzi R.A., Gemma A., Marra C., et al. Chronic obstructive pulmonary disease. An independent risk factor for cognitive decline? Age Ageing. 2001;30(2):107–111.

8. Hung W.W., Wisnivesky J.P., Siu A.L., Ross J.S. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(2):134–137.

9. Schou L., Østergaard B., Rasmussen L.S., Rydahl-Hansen S., Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease. J Clin Nurs. 2012;21(3-4):418–426.

10. Yohannes A.M., Chen W., Moga A.M., Leroi I., Connolly M.J. Cognitive impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(9):A717.

11. Cleutjens F.A., Spruit M.A., Ponds R.W., et al. Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2018;15(2):147–157.

12. Torres-Sánchez I., Rodríguez-Alzueta E., Cabrera-Martos I., López-Torres I., Moreno-Ramírez M.P., Valenza M.C. Cognitive impairment in COPD: a systematic review. J Cardiopulm Rehabil Prev. 2015; 35(4):273–280.

13. Zhang X., et al. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Front Physiol. 2021;12:719054.

14. Dodd J.W., Charlton R.A., van den Broek M.D., Jones P.W. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest. 2013;144(4):119–127.

15. Antonelli-Incalzi R., Corsonello A., Trojano L., et al. Screening for cognitive impairment in chronic obstructive pulmonary disease. Respir Med. 2008;102(4):612–618.

16. Yohannes A.M., Chen W., Moga A.M., et al. Cognitive impairment in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2017;11(3): 233–242.

17. Dodd J.W. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922.

18. Torres-Sánchez I., Valenza M.C., Cebrián A.M., et al. Respiratory rehabilitation and cognitive function in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2125–2133.

19. Muellerova H., Agusti A., Erqou S., et al. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163–1178.

20. Chen W., Thomas J., Sadatsafavi M., FitzGerald J.M. Risk of cardiovascular comorbidity in patients with COPD: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639.

21. Rabe K.F., Hurst J.R., Suissa S. Cardiovascular disease and COPD: dangerous liaisons? Eur Respir Rev. 2018;27(149):180057.

22. Waschki B., Kirsten A., Holz O., et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD. Chest. 2011;140(2): 331–342.

23. Fabbri L.M., Luppi F., Beghe B., Rabe K.F. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212.

24. Zuo L., Nogueira L., Hogan M.C. Reactive oxygen species, oxidative stress, and hypoxia-induced mitochondrial dysfunction. Respir Physiol Ne-urobiol. 2011;178(3):298–305.

25. Barnes P.J. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544.

26. Kirkham P.A., Barnes P.J. Oxidative stress in COPD. Chest. 2013;144(1):266–273.

27. Rahman I., Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219–242.

28. MacNee W. Oxidative stress and lung inflammation in airway diseases. Eur J Pharmacol. 20 01;429(1-3):195–207.

29. Foronjy R., D'Armiento J. The effect of cigarette smoke-derived oxidants on the lung. Clin Chest Med. 2007;28(4):705–719.

30. He Z., et al. COPD and cognitive impairment: a review of associated factors and intervention strategies. Front Psychiatry. 2025;16:1714708.